Theriva Biologics Financial Health

Short Term Liabilities: TOVX's short term assets ($52.7M) exceed its short term liabilities ($13.2M).

Long Term Liabilities: TOVX's short term assets ($52.7M) exceed its long term liabilities ($7.4M).

Debt Level: TOVX has more cash than its total debt.

Reducing Debt: TOVX's debt to equity ratio has increased from 0% to 0.4% over the past 5 years.

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: TOVX has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: TOVX has sufficient cash runway for 2.3 years if free cash flow continues to grow at historical rates of 15% each year.

• Healthy companies in the Pharmaceuticals & Biotech industry.